189 related articles for article (PubMed ID: 28952025)
1. Pathological significance and prognostic significance of FES expression in bladder cancer vary according to tumor grade.
Asai A; Miyata Y; Takehara K; Kanda S; Watanabe SI; Greer PA; Sakai H
J Cancer Res Clin Oncol; 2018 Jan; 144(1):21-31. PubMed ID: 28952025
[TBL] [Abstract][Full Text] [Related]
2. Comprehensive analysis of differentially expressed genes associated with PLK1 in bladder cancer.
Zhang Z; Zhang G; Gao Z; Li S; Li Z; Bi J; Liu X; Li Z; Kong C
BMC Cancer; 2017 Dec; 17(1):861. PubMed ID: 29246203
[TBL] [Abstract][Full Text] [Related]
3. Increased expression of α-actinin-4 is associated with unfavorable pathological features and invasiveness of bladder cancer.
Yoshii H; Ito K; Asano T; Horiguchi A; Hayakawa M; Asano T
Oncol Rep; 2013 Sep; 30(3):1073-80. PubMed ID: 23817592
[TBL] [Abstract][Full Text] [Related]
4. SOX10 is over-expressed in bladder cancer and contributes to the malignant bladder cancer cell behaviors.
Yin H; Qin C; Zhao Y; Du Y; Sheng Z; Wang Q; Song Q; Chen L; Liu C; Xu T
Clin Transl Oncol; 2017 Aug; 19(8):1035-1044. PubMed ID: 28258492
[TBL] [Abstract][Full Text] [Related]
5. Increased expression of SPRY4-IT1 predicts poor prognosis and promotes tumor growth and metastasis in bladder cancer.
Zhao XL; Zhao ZH; Xu WC; Hou JQ; Du XY
Int J Clin Exp Pathol; 2015; 8(2):1954-60. PubMed ID: 25973088
[TBL] [Abstract][Full Text] [Related]
6. High expression of polo-like kinase 1 is associated with the metastasis and recurrence in urothelial carcinoma of bladder.
Zhang Z; Zhang G; Kong C
Urol Oncol; 2013 Oct; 31(7):1222-30. PubMed ID: 22192978
[TBL] [Abstract][Full Text] [Related]
7. Slug contributes to cadherin switch and malignant progression in muscle-invasive bladder cancer development.
Wu K; Zeng J; Zhou J; Fan J; Chen Y; Wang Z; Zhang T; Wang X; He D
Urol Oncol; 2013 Nov; 31(8):1751-60. PubMed ID: 22421353
[TBL] [Abstract][Full Text] [Related]
8. Pathological significance and predictive value for biochemical recurrence of c-Fes expression in prostate cancer.
Miyata Y; Watanabe S; Matsuo T; Hayashi T; Sakai H; Xuan JW; Greer PA; Kanda S
Prostate; 2012 Feb; 72(2):201-8. PubMed ID: 21563194
[TBL] [Abstract][Full Text] [Related]
9. Rab23 is overexpressed in human bladder cancer and promotes cancer cell proliferation and invasion.
Jiang Y; Han Y; Sun C; Han C; Han N; Zhi W; Qiao Q
Tumour Biol; 2016 Jun; 37(6):8131-8. PubMed ID: 26715272
[TBL] [Abstract][Full Text] [Related]
10. DDR2 overexpression in urothelial carcinoma indicates an unfavorable prognosis: a large cohort study.
Tsai MC; Li WM; Huang CN; Ke HL; Li CC; Yeh HC; Chan TC; Liang PI; Yeh BW; Wu WJ; Lim SW; Li CF
Oncotarget; 2016 Nov; 7(48):78918-78931. PubMed ID: 27793038
[TBL] [Abstract][Full Text] [Related]
11. PCMT1 is an unfavorable predictor and functions as an oncogene in bladder cancer.
Dong L; Li Y; Xue D; Liu Y
IUBMB Life; 2018 Apr; 70(4):291-299. PubMed ID: 29517839
[TBL] [Abstract][Full Text] [Related]
12. GOLPH3 is a potential therapeutic target and a prognostic indicator of poor survival in bladder cancer treated by cystectomy.
Zhang Q; Zhuang J; Deng Y; Zhao X; Tang B; Yao D; Zhao W; Chang C; Lu Q; Chen W; Zhang S; Ji C; Cao L; Guo H
Oncotarget; 2015 Oct; 6(31):32177-92. PubMed ID: 26375441
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of long non-coding RNA TUG1 predicts poor prognosis and promotes cancer cell proliferation and migration in high-grade muscle-invasive bladder cancer.
Iliev R; Kleinova R; Juracek J; Dolezel J; Ozanova Z; Fedorko M; Pacik D; Svoboda M; Stanik M; Slaby O
Tumour Biol; 2016 Oct; 37(10):13385-13390. PubMed ID: 27460088
[TBL] [Abstract][Full Text] [Related]
14. Knockdown BMI1 expression inhibits proliferation and invasion in human bladder cancer T24 cells.
Liang W; Zhu D; Cui X; Su J; Liu H; Han J; Zhao F; Xie W
Mol Cell Biochem; 2013 Oct; 382(1-2):283-91. PubMed ID: 23820733
[TBL] [Abstract][Full Text] [Related]
15. mTORC2 activation is regulated by the urokinase receptor (uPAR) in bladder cancer.
Hau AM; Leivo MZ; Gilder AS; Hu JJ; Gonias SL; Hansel DE
Cell Signal; 2017 Jan; 29():96-106. PubMed ID: 27777073
[TBL] [Abstract][Full Text] [Related]
16. The enhanced expression of estrogen-related receptor α in human bladder cancer tissues and the effects of estrogen-related receptor α knockdown on bladder cancer cells.
Ye X; Guo J; Zhang H; Meng Q; Ma Y; Lin R; Yi X; Lu H; Bai X; Cheng J
J Cell Biochem; 2019 Aug; 120(8):13841-13852. PubMed ID: 30977157
[TBL] [Abstract][Full Text] [Related]
17. Functional characterization of the tumor suppressor CMTM8 and its association with prognosis in bladder cancer.
Zhang S; Pei X; Hu H; Zhang W; Mo X; Song Q; Zhang Y; Xu K; Wang Y; Na Y
Tumour Biol; 2016 May; 37(5):6217-25. PubMed ID: 26615421
[TBL] [Abstract][Full Text] [Related]
18. The Role of Interleukin-1-Receptor-Antagonist in Bladder Cancer Cell Migration and Invasion.
Schneider L; Liu J; Zhang C; Azoitei A; Meessen S; Zheng X; Cremer C; Gorzelanny C; Kempe-Gonzales S; Brunner C; Wezel F; Bolenz C; Gunes C; John A
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34070905
[TBL] [Abstract][Full Text] [Related]
19. Decreased expression of SRY-box containing gene 30 is related to malignant phenotypes of human bladder cancer and correlates with poor prognosis.
Liu Y; Wang H; Zhong J; Wu C; Yang G; Zhong Y; Zhang J; Tang A
BMC Cancer; 2018 Jun; 18(1):642. PubMed ID: 29880037
[TBL] [Abstract][Full Text] [Related]
20. miR-451 suppresses bladder cancer cell migration and invasion via directly targeting c-Myc.
Wang J; Zhao X; Shi J; Pan Y; Chen Q; Leng P; Wang Y
Oncol Rep; 2016 Oct; 36(4):2049-58. PubMed ID: 27571748
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]